SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
1点点
Lv1
40 积分
2023-10-07 加入
最近求助
最近应助
互助留言
Prevalence of subclinical hypothyroidism and longitudinal thyroid stimulating hormone changes in youth with metabolic dysfunction-associated steatotic liver disease: an observational study
6天前
已完结
[Chinese guideline for diagnosis and management of drug-induced liver injury (2023 version)]
28天前
已完结
FAK inhibition delays liver repair after acetaminophen-induced acute liver injury by suppressing hepatocyte proliferation and macrophage recruitment
30天前
已完结
Metabolomics and Cytokine Analysis for Identification of Severe Drug-Induced Liver Injury
1个月前
已完结
Sintilimab plus bevacizumab combined with radiotherapy as first-line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A multicenter, single-arm, phase 2 study
1个月前
已完结
IL-8 exacerbates CCl4-induced liver fibrosis in human IL-8-expressing mice via the PI3K/Akt/HIF-1α pathway
1个月前
已完结
The chemokine CXCL14 is a novel early prognostic biomarker for poor outcome in acetaminophen-induced acute liver failure
1个月前
已完结
Health-Related quality of life (HRQL) assessments in a 52-Week, Double-Blind, randomized, Placebo-Controlled phase 3 study of resmetirom (MGL-3196) in patients with metabolic dysfunction associated steatohepatitis (MASH) and fibrosis
2个月前
已完结
Health-Related quality of life (HRQL) assessments in a 52-Week, Double-Blind, randomized, Placebo-Controlled phase 3 study of resmetirom (MGL-3196) in patients with metabolic dysfunction associated steatohepatitis (MASH) and fibrosis
2个月前
已完结
Associations of the EAT-Lancet reference diet with metabolic dysfunction-associated steatotic liver disease and its severity: a multi-cohort study
3个月前
已完结
没有进行任何应助
速度真快,速度真快,帮大忙了
28天前
么么哒,帮大忙了
30天前
帮大忙了
1个月前
帮大忙了,帮大忙了,帮大忙了,帮大忙了,感谢
3个月前
帮大忙了,点赞,感谢,么么哒
4个月前
帮大忙了,么么哒
5个月前
牛 太棒啦
5个月前
帮大忙了
6个月前
么么哒
6个月前
么么哒
6个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论